About Alucent Biomedical
Alucent Biomedical is a private company based in Salt Lake City, Utah. It has reported $46,599,999 raised in three offerings on Form D since January 2015.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Apr 17, 2023 | Apr 20, 2023 | $11,200,000fully sold | 1 | $11.2M | EquityRule 506(b) | Form D ↗ |
| Sep 30, 2020 | Oct 15, 2020 | $34,999,999fully sold | 3 | $11.6M | EquityRule 506(b) | Form D ↗ |
| Jan 26, 2015 | Jan 27, 2015 | $400,000fully sold | 1 | $400K | EquityRule 506(b) | Form D ↗ |
| Total, three offerings | $46,599,999 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Alucent Biomedical's Form D filed Apr 20, 2023.
Earlier filings also listed Scott Mayfield (executive officer, last listed Oct 2020), Ryan Hansen (director, last listed Oct 2020), Pat Costello (director, last listed Oct 2020), Michael Elliot (director, last listed Jan 2015), Julie Norton (director, last listed Jan 2015), Fred Slunecka (director, last listed Jan 2015) and David Kapaska (director, last listed Jan 2015).